Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study
Go back to Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study| (NASDAQ: MIRM) | Delayed: 96.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.31 | 52 Week High | $ | |||
| Open | $96.31 | 52 Week Low | $ | |||
| Day High | $96.78 | P/E | N/A | |||
| Day Low | $96.30 | EPS | $ | |||
| Volume | 11,947 | |||||
